Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older
Clinical trial NCT00848848 · COMPLETED
Trial details
- NCT number
- NCT00848848
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2009-04-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.